About this event
About this Event:
According to the Alzheimer’s Association, the population of Americans age 65 and older is projected to grow from 58 million in 2022 to 82 million by 2050. In fact, by 2030, all members of the of the baby-boom generation (Americans born between 1946 and 1964) will be age 65 or older, the age range at greatest risk for developing Alzheimer’s and other dementias. While not everyone experiencing cognitive decline has or will develop Alzheimer's disease or related dementias, early detection and diagnosis can help patients, families, and physicians navigate next steps. Research advancements in clinical assessments, psychometric testing, and emerging blood-based and biomarkers tests continue to show promise in detecting disease at earlier stages. This course will review the essential information healthcare professionals in Illinois need in order to stay up-to-date with the latest screening tools, diagnostic criteria, and management recommendations for Alzheimer’s disease and related dementias. Physicians are required to complete a one-hour course in training on the diagnosis, treatment, and care of individuals with Alzheimer's disease and other dementias per renewal period to be licensed in Illinois.
Join the Illinois State Medical Society for this webinar presented by Daniel A. Llano, M.D., Ph.D., from Carle Illinois College of Medicine & Carle Foundation Hospital, to learn the most current and essential information Illinois medical professionals need to know about Alzheimer’s disease and related dementias.
Presenter
Dr. Llano received his M.D. from the University of Illinois College of Medicine, neurology training at the Massachusetts General Hospital/Brigham and Women’s Hospital and training in behavioral neuroscience at the University of Chicago. He currently works at the Carle Illinois College of Medicine and Carle Foundation Hospital where he sees patients with cognitive and behavioral disorders and conducts research on aging and aging-related disorders.
Who Can Attend
Registration is limited to ISMS members, ISMIE policy holders and their employed staff.
Learning Objectives
At the conclusion of this activity, learners will be able to:
- Outline the differential diagnosis for patients presenting with memory loss
- Communicate current and emerging best practices for timely screening and diagnosis of Alzheimer’s disease and other dementias
- Identify the stages and risk factors of Alzheimer’s disease and other dementias
- Recognize FDA-approved treatment options that may address some symptoms of Alzheimer’s and other dementias
- Describe current scientific efforts to advance Alzheimer’s research
Accreditation
The Illinois State Medical Society designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Designation
The Illinois State Medical Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Disclosure
There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.
Hosted by
-
Guest speaker
Daniel LlanoG
